Showing results (91-100 of 164) with videos related to
Sort By:
Pageof 17
Eclinicalmedicine|March 4, 2025
Ensartinib for advanced or metastatic non-small-cell lung cancer with MET exon 14 skipping mutations (EMBRACE): a multi-center, single-arm, phase 2 trialYang Xia, Panwen Tian, Mo Zhou, et al.Acta Biomaterialia|July 27, 2024
Crizotinib resistance reversal in ALK-positive lung cancer through zeolitic imidazolate framework-based mitochondrial damageZhouhua Li, Xuehua Ma, Yanqiang Yang, et al.Oncogene|October 22, 2021
DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinomaSk Kayum Alam, Yongchang Zhang, Li Wang, et al.Cancer Pathogenesis and Therapy|November 3, 2025
Radiotherapy combined with first-line anti-programmed cell death protein 1 (PD-1) immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer: A bicentric retrospective studyYu Huang, Peng Ding, Ruiguang Zhang, et al.Cancer Immunology, Immunotherapy : CII|February 10, 2021
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in ChinaXiangyu Zhang, Liang Zeng, Yizhi Li, et al.Cancer|December 8, 2025
Overall survival according to time-of-day of immunochemotherapy for extensive-stage small cell lung cancerZhe Huang, Zhaohui Ruan, Shidong Xu, et al.Cell Death & Disease|August 16, 2022
FOXA1 prevents nutrients deprivation induced autophagic cell death through inducing loss of imprinting of IGF2 in lung adenocarcinomaJunjun Li, Yongchang Zhang, Li Wang, et al.NPJ Precision Oncology|April 1, 2022
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangementsYongchang Zhang, Zhe Huang, Liang Zeng, et al.Cancer Medicine|November 7, 2022
The rational application of liquid biopsy based on next-generation sequencing in advanced non-small cell lung cancerChenglong Zhao, Jianghua Li, Yongchang Zhang, et al.Journal for Immunotherapy of Cancer|September 20, 2023
Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approachJie Zhao, Yayi He, Xue Yang, et al.Pageof 17